European Healthtech startup funding raised during Q1 2021.
In Q1 2021, 96 European Healthtech companies raised a combined €1.6B across 97 funding rounds, up 71.5% versus Q1 2020. UK led by capital raised, and Ada Ventures was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Immunocore | Debt | Feb 2021 | €190M |
| Atai Life Sciences | Series D+ | Mar 2021 | €131M |
| IO Biotech | Series B | Jan 2021 | €127M |
| Melio | Series C | Jan 2021 |
14 exits · €911M disclosed.
| Arvelle Therapeutics | Acquisition | Jan 2021 | €784M |
| Ginolis | Acquisition | Feb 2021 | €70M |
| MatTek | Acquisition | Mar 2021 | €57M |
| €90M |
| Evox Therapeutics | Series C | Feb 2021 | €80M |
| Monte Rosa | Series C | Mar 2021 | €80M |
| Immunocore | Series C | Jan 2021 | €62M |
| Eleva | Other | Jan 2021 | €60M |
| dariohealth | Growth/Late | Jan 2021 | €58M |
| MedAlliance | Other | Mar 2021 | €42M |
| Leyden Labs | Series A | Mar 2021 | €40M |
| PlusDental | Other | Mar 2021 | €35M |
| Ukko | Series B | Jan 2021 | €33M |
| Corwave | Series C | Jan 2021 | €33M |
| Ibex Medical Analytics | Series B | Mar 2021 | €32M |
